Loading results ...
 

Blog Posts

Smokescreen: A platform for genetic research on smoking, addiction and treatment approaches

Addiction is a complex phenotype with many genetic and non-genetic factors influencing risk and response to treatment. To develop individualized prevention and treatment strategies, the National Institute on Drug Abuse (NIDA) saw a need for a common genotyping array specifically designed for addiction research. NIDA awarded BioRealm with a Small Business Innovative Research (SBIR) contract […]

Read more »

The National Patient-Centered Clinical Research Network focuses on improving capacity to conduct CER through research network

The Patient-Centered Outcomes Research Institute (PCORI) is authorized by Congress to conduct research to provide information about the best available evidence to help patients and their healthcare providers make more informed decisions.  PCORI funds clinical effectiveness research (CER) and supports work that will improve the methods to conduct such studies.  This support comes from the […]

Read more »

Data Virtualization enables business agility in Life Sciences

The healthcare and life sciences industry is undergoing an upheaval of change that creates opportunities for the most agile firms to innovate for better outcomes and lower cost. HIPAA compliance and the Affordable Care Act are putting more focus on consumer-driven healthcare. Personalized medicine is becoming an even greater reality as medical innovations are fostering […]

Read more »

The Value of Healthy Donor Biospecimens and Data in Supporting Breast Cancer Research

Medical research has historically been focused on the recruitment of study participants who have been diagnosed with a specific medical condition with the goal of finding a therapeutic intervention to treat or cure the condition. However, in the case of breast cancer research, there are many studies and evidence that support the value and benefit […]

Read more »

Pharmacogenomic Research as an Integral Component of Drug Development

The ability to conduct unbiased, genome-wide pharmacogenomic research has been greatly enhanced by the convergence of several factors. First, the cost of performing genome-wide genotyping on a Single Nucleotide Polymorphism Single (SNP) array is now about par with many other clinical assays routinely performed (~$100). Further, Whole Exome Sequencing (WES) now costs less than $1000 […]

Read more »

2015 EU Data Protection Regulation – Impact on Research Updates

Important decisions are soon to be made that will govern the use of personal data to support research studies in Europe. In 1995, the European Union passed an EU Data Protection Directive (EU 95/96) aimed at protecting the data privacy of EU residents by providing EU citizens with fundamental privacy rights such as the right […]

Read more »

Turning Data into Intelligence

Today’s organizations are built on data. Tons and tons of data. Taking that data and turning it into intelligence is one of the most common challenges in clinical research and drug development organizations. Data by itself doesn’t provide value to an organization. What do I mean by that? Data itself is just that: words and/or […]

Read more »

Growing importance of sample data integration to researchers

The need for high-quality samples and corresponding data by medical researchers is predicted to be increasing in importance at an exponential rate over the next few years. The leading research factors driving this demand are increasing investment in chronic diseases such as cancer, innovation in genomics and an increasing focus on regenerative medicine. Recently, the […]

Read more »

New Technologies Advancing Translational Research and Biomarker Development

In today’s era of personalized medicine, new advancements in biospecimen management, science and technology are enabling researchers to introduce innovative medical therapies to the market. Technology continues to be a key driver that is impacting how biological samples are being used to make more specific and sensitive measurements of molecular biomarkers. The discovery of biomarkers […]

Read more »

BioStorage Firmly Behind the Scenes of Personalized Medicine

Personalized medicine, the precise targeting of specific drugs to treat specific patients based on the genetic details of their disease, is quickly becoming a reality. In fact, the precipitous decline in the cost of sequencing patients’ specimens is leading to a flood of genetic information that is being exploited to diagnose and treat patients. An […]

Read more »